Levodopa analgesia in experimental neuropathic pain

Brain Research Bulletin

Volumn 83, Issue 6, 2010, Pages 304-309

  Cobacho, Nuria ^a   De la Calle, José L ^a   González Escalada J R , José R ^a   Paíno, Carlos L ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Allodynia; CCI; D2 receptors; Intrathecal; Rats; Sulpiride

Indexed keywords

LEVODOPA;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; MALE; MONONEUROPATHY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FUNCTIONAL LATERALITY; HYPERALGESIA; LEVODOPA; MALE; MOTOR ACTIVITY; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; SULPIRIDE; TIME FACTORS;

EID: 78149281636     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.08.012     Document Type: Article

References (49)

1. Ansah O.B., Leite-Almeida H., Wei H., Pertovaara A. Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat. Exp. Neurol. 2007, 205:536-546.
2. Barasi S., Ben-Sreti M.M., Clatworthy A.L., Duggal K.N., Gonzalez J.P., Robertson J., Rooney K.F., Sewell R.D. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. Br. J. Pharmacol. 1987, 90:15-22.
3. Barasi S., Duggal K.N. The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat. Eur. J. Pharmacol. 1985, 117:287-294.
4. Bardin L., Schmidt J., Alloui A., Eschalier A. Effect of intrathecal administration of serotonin in chronic pain models in rats. Eur. J. Pharmacol. 2000, 409:37-43.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
6. Bjorklund A., Skagerberg G. Evidence for a major spinal cord projection from the diencephalic A11 dopamine cell group in the rat using transmitter-specific fluorescent retrograde tracing. Brain Res. 1979, 177:170-175.
7. Brefel-Courbon C., Payoux P., Thalamas C., Ory F., Quelven I., Chollet F., Montastruc J.L., Rascol O. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study. Mov.Disord. 2005, 20:1557-1563.
8. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Method 1994, 53:55-63.
9. Cobacho N., Serrano A.B., Casarejos M.J., Mena M.A., Paino C.L. Use of transduced adipose tissue stromal cells as biologic minipumps to deliver levodopa for the treatment of neuropathic pain: possibilities and limitations. Cell Transplant. 2009, 18:1341-1358.
10. Conti C.F., de Oliveira M.M., Andriolo R.B., Saconato H., Atallah A.N., Valbuza J.S., Coin de Carvalho L.B., do Prado G.F. Levodopa for idiopathic restless legs syndrome: evidence-based review. Mov. Disord. 2007, 22:1943-1951.
11. De la Calle J.L., Mena M.A., Gonzalez-Escalada J.R., Paino C.L. Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain. Brain Res. Bull. 2002, 59:205-211.
12. De la Calle J.L., Paino C.L. A procedure for direct lumbar puncture in rats. Brain Res. Bull. 2002, 59:245-250.
13. Dickey R.P., Minton J.P. Levodopa relief of bone pain from breast cancer. New Engl. J. Med. 1972, 286:843.
14. Dixon W.J. Efficient analysis of experimental observations. Annu. Rev. Pharmacol. Toxicol. 1980, 20:441-462.
15. Ertas M., Sagduyu A., Arac N., Uludag B., Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain 1998, 75:257-259.
16. Finnerup N.B., Otto M., Mcquay H.J., Jensen T.S., Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
17. Fleetwood-Walker S.M., Hope P.J., Mitchell R. Antinociceptive actions of descending dopaminergic tracts on cat and rat dorsal horn somatosensory neurones. J. Physiol. 1988, 399:335-348.
18. Fleetwood-Walker S.M., Mitchell R., Hope P.J., Molony V., Iggo A. An alpha 2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res. 1985, 334:243-254.
19. Gao X., Zhang Y.-Q., Wu G.-C. Effects of dopaminergic agents on carrageenan hyperalgesia after intrathecal administration to rats. Eur. J. Pharmacol. 2001, 418:73-77.
20. Gerdelat-Mas A., Simonetta-Moreau M., Thalamas C., Ory-Magne F., Slaoui T., Rascol O., Brefel-Courbon C. Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study. J. Neurol. Neurosur. Psychiatry 2007, 78:1140-1142.
21. Holstege J.C., Van Dijken H., Buijs R.M., Goedknegt H., Gosens T., Bongers C.M. Distribution of dopamine immunoreactivity in the rat, cat and monkey spinal cord. J. Comp. Neurol. 1996, 376:631-652.
22. R. Hulse, D. Wynick, L.F. Donaldson, Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia, Eur. J. Pain. 14 565.e01-565.e10.
23. Jensen T.S., Yaksh T.L. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res. 1984, 296:285-293.
24. Kernbaum S., Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA 1981, 246:132-134.
25. Magnusson J.E., Fisher K. The involvement of dopamine in nociception: the role of D1 and D2 receptors in the dorsolateral striatum. Brain Res. 2000, 855:260-266.
26. Mercuri N.B., Bernardi G. The 'magic' of l-dopa: why is it the gold standard Parkinson's disease therapy?. Trends Pharmacol. Sci. 2005, 26:341-344.
27. Michael-Titus A., Bousselmame R., Costentin J. Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. Eur J. Pharmacol. 1990, 187:201-207.
28. Mico J.A., Ardid D., Berrocoso E., Eschalier A. Antidepressants and pain. Trends Pharmacol. Sci. 2006, 27:348-354.
29. Millan M.J. The induction of pain: an integrative review. Prog. Neurobiol. 1999, 57:1-164.
30. Millan M.J. Descending control of pain. Prog. Neurobiol. 2002, 66:355-474.
31. Munro G. Dopamine D1 and D2 receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test. Eur. J. Pharmacol. 2007, 575:66-74.
32. Nixon D.W. Letter: Use of l-dopa to relieve pain from bone metastases. New Engl. J. Med. 1975, 292:647.
33. Ondo W.G., He Y., Rajasekaran S., Le W.D. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov.Disord. 2000, 15:154-158.
34. Paalzow G.H. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses. J. Pharmacol. Exp. Ther. 1992, 263:470-479.
35. Pertovaara A., Wei H. Dual influence of the striatum on neuropathic hypersensitivity. Pain 2008, 137:50-59.
36. Rojas-Corrales M.O., Casas J., Moreno-Brea M.R., Gibert-Rahola J., Mico J.A. Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. Eur. Neuropsychopharmacol 2003, 13:355-363.
37. Schestatsky P., Kumru H., Valls-Sole J., Valldeoriola F., Marti M.J., Tolosa E., Chaves M.L. Neurophysiologic study of central pain in patients with Parkinson disease. Neurology 2007, 69:2162-2169.
38. Sheng H.Y., Qu C.L., Huo F.Q., Du J.Q., Tang J.S. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism. Exp. Neurol. 2009, 215:128-134.
39. Shimizu T., Iwata S., Morioka H., Masuyama T., Fukuda T., Nomoto M. Antinociceptive mechanism of l-DOPA. Pain 2004, 110:246-249.
40. Skagerberg G., Lindvall O. Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat. Brain Res. 1985, 342:340-351.
41. Stiasny-Kolster K., Magerl W., Oertel W.H., Moller J.C., Treede R.D. Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain 2004, 127:773-782.
42. Tamae A., Nakatsuka T., Koga K., Kato G., Furue H., Katafuchi T., Yoshimura M. Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors. J. Physiol. 2005, 568:243-253.
43. Taylor B.K., Joshi C., Uppal H. Stimulation of dopamine D2 receptors in the nucleus accumbens inhibits inflammatory pain. Brain Res. 2003, 987:135-143.
44. Wong M.C., Chung J.W., Wong T.K. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ 2007, 335:87.
45. Yaksh T.L., Pogrel J.W., Lee Y.W., Chaplan S.R. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther. 1995, 272:207-214.
46. Yaksh T.L., Wilson P.R. Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 1979, 208:446-453.
47. Yokogawa F., Kiuchi Y., Ishikawa Y., Otsuka N., Masuda Y., Oguchi K., Hosoyamada A. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth. Analg. 2002, 95:163-168.
48. Zhao H., Zhu W., Pan T., Xie W., Zhang A., Ondo W.G., Le W. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J. Neurosci. Res. 2007, 85:1065-1076.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.